
Exagen XGN
€ 2.32
-1.28%
Geschäftsbericht 2025
hinzugefügt 10.03.2026
Exagen EV/EBITDA 2011-2026 | XGN
EV/EBITDA Jährlich Exagen
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| -2.2 | -13.3 | -3.94 | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| -2.2 | -13.3 | -6.47 |
EV/EBITDA anderer Aktien in der Diagnostik & Forschung
| Name | EV/EBITDA | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Akumin
AKU
|
28.1 | - | -17.87 % | $ 25.9 M | ||
|
Centogene N.V.
CNTG
|
0.387 | - | -6.23 % | $ 30.6 M | ||
|
Agilent Technologies
A
|
27.4 | $ 114.87 | -0.65 % | $ 34.9 B | ||
|
Accelerate Diagnostics
AXDX
|
-5.56 | - | -61.36 % | $ 2.46 M | ||
|
Chembio Diagnostics
CEMI
|
-1.23 | - | 0.22 % | $ 16.8 M | ||
|
Co-Diagnostics
CODX
|
3.62 | $ 1.61 | -2.35 % | $ 2.14 M | ||
|
Aspira Women's Health
AWH
|
-2.63 | - | -6.19 % | $ 10.5 M | ||
|
Biocept
BIOC
|
-26.9 | - | -13.05 % | $ 7.29 M | ||
|
Castle Biosciences
CSTL
|
-21.2 | $ 24.61 | -1.48 % | $ 684 M | ||
|
Check-Cap Ltd.
CHEK
|
-0.674 | - | - | $ 9.42 M | ||
|
Enzo Biochem
ENZ
|
58.3 | - | -8.98 % | $ 14.8 K | ||
|
CareDx, Inc
CDNA
|
-100 | $ 21.85 | - | $ 1.16 B | ||
|
Oxford Immunotec Global PLC
OXFD
|
-73.4 | - | - | $ 562 M | ||
|
Illumina
ILMN
|
70.5 | $ 126.55 | -1.54 % | $ 20.1 B | ||
|
DermTech
DMTK
|
-2.44 | - | -11.32 % | $ 2.94 M | ||
|
Exact Sciences Corporation
EXAS
|
-20.8 | - | - | $ 19.8 B | ||
|
Fulgent Genetics
FLGT
|
2.58 | $ 15.29 | -1.99 % | $ 462 M | ||
|
HTG Molecular Diagnostics
HTGM
|
-1.42 | - | -20.0 % | $ 1.06 M | ||
|
Global Cord Blood Corporation
CO
|
-3.52 | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
-13.6 | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
-2.67 | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
-2.67 | - | 0.12 % | $ 80.1 M | ||
|
Lantheus Holdings
LNTH
|
-187 | $ 83.38 | -0.87 % | $ 5.63 B | ||
|
Charles River Laboratories International
CRL
|
22 | $ 166.76 | -2.61 % | $ 8.27 B | ||
|
PRA Health Sciences, Inc.
PRAH
|
20.8 | - | - | $ 10.7 B | ||
|
Guardant Health
GH
|
-28.8 | $ 82.62 | -6.64 % | $ 10.4 B | ||
|
National Research Corporation
NRC
|
21 | $ 16.99 | -0.73 % | $ 380 M | ||
|
Heska Corporation
HSKA
|
141 | - | - | $ 1.31 B | ||
|
Interpace Biosciences
IDXG
|
-6.02 | $ 1.93 | - | $ 8.54 M | ||
|
Koninklijke Philips N.V.
PHG
|
55.6 | $ 27.13 | -1.49 % | $ 20 B | ||
|
Precipio
PRPO
|
-1.8 | $ 30.2 | -1.64 % | $ 48.5 M | ||
|
Personalis
PSNL
|
-7.07 | $ 5.54 | -7.05 % | $ 328 M | ||
|
Senseonics Holdings
SENS
|
-13.8 | $ 7.28 | 0.14 % | $ 304 M | ||
|
Medpace Holdings
MEDP
|
30.7 | $ 416.18 | -1.23 % | $ 12 B | ||
|
QIAGEN N.V.
QGEN
|
13.2 | - | - | $ 10.6 B | ||
|
Motus GI Holdings
MOTS
|
0.351 | - | -34.28 % | $ 263 K | ||
|
Biomerica
BMRA
|
-6.24 | $ 2.13 | -2.06 % | $ 4.89 M | ||
|
ICON Public Limited Company
ICLR
|
38 | $ 101.17 | -1.98 % | $ 8.34 B | ||
|
Laboratory Corporation of America Holdings
LH
|
8.7 | $ 261.16 | -0.86 % | $ 21.7 B | ||
|
Thermo Fisher Scientific
TMO
|
19.3 | $ 469.03 | 0.21 % | $ 177 B | ||
|
Trinity Biotech plc
TRIB
|
12.6 | $ 0.62 | -3.8 % | $ 61.9 M | ||
|
Neogen Corporation
NEOG
|
40.3 | $ 9.29 | -1.75 % | $ 2.01 B | ||
|
Celcuity
CELC
|
-2.38 | $ 122.03 | -2.9 % | $ 5.71 B | ||
|
Twist Bioscience Corporation
TWST
|
-23.6 | $ 59.4 | -2.62 % | $ 3.55 B | ||
|
NeoGenomics
NEO
|
-33.5 | $ 8.67 | 0.7 % | $ 1.11 B | ||
|
Myriad Genetics
MYGN
|
-17.2 | $ 4.83 | -0.1 % | $ 447 M | ||
|
Natera
NTRA
|
-19.5 | $ 199.57 | -2.36 % | $ 19.6 B | ||
|
Quest Diagnostics Incorporated
DGX
|
5.51 | $ 196.11 | -0.26 % | $ 21.8 B | ||
|
Invitae Corporation
NVTA
|
-10.7 | - | - | $ 21.2 M | ||
|
OpGen
OPGN
|
0.274 | - | -16.95 % | $ 1.54 M |